John Standley - Rite Aid Chairman, CEO and Chairman of Executive Committee

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
RAD -- USA Stock  

Fiscal Quarter End: 31st of May 2020  

  Chairman
Mr. John T. Standley is Director of the Company. He is was Chairman of the Board since June 21, 2012, Chief Executive Officer since June 2010 and was President from September 2008 until June 2013. Mr. Standley served as the Chief Operating Officer from September 2008 until June 2010. He also served as a consultant to Rite Aid from July 2008 to September 2008. From August 2005 through December 2007, Mr. Standley served as Chief Executive Officer and was a member of the board of directors of Pathmark Stores, Inc. From June 2002 to August 2005, he served as Senior Executive Vice President and Chief Administrative Officer of Rite Aid and, in addition, in January 2004 was appointed Chief Financial Officer of Rite Aid. He had served as Senior Executive Vice President and Chief Financial Officer of Rite Aid from September 2000 to June 2002 and had served as Executive Vice President and Chief Financial Officer of Rite Aid from December 1999 until September 2000. Mr. Standley served on the SUPERVALU INC. board of directors from May 2013 to July 2015. Mr. Standley currently serves on the National Association of Chain Drug Stores board of directors and is a member of the Board Executive Committee. He also serves on the board of directors of CarMax, Inc.
Age: 54  Chairman Since 2019      
717 975-5905  www.riteaid.com

John Standley Latest Insider Activity

Rite Aid Management Efficiency

Rite Aid has Return on Asset of (5.0E-4) % which means that on every $100 spent on asset it lost $5.0E-4. This is way below average. In the same way, it shows return on shareholders equity (ROE) of (0.4987) % meaning that it generated no profit with money invested by stockholders. Rite Aid management efficiency ratios could be used to measure of how well the company is managing its routine affairs as well as how well it utilizes its assets and manages liabilities. Rite Aid Return on Invested Capital is expected to slightly increase based on the last few years of reporting. The last year's Return on Invested Capital was at 0.07. The current year Return on Sales is expected to grow to 0.030103, whereas Return on Average Assets are expected to decline to (5.45) . Rite Aid Current Assets are expected to significantly decrease based on the last few years of reporting. The last year's Current Assets were at 3.7 Billion. The current year Goodwill and Intangible Assets is expected to grow to about 665.6 M, whereas Tax Assets are expected to decline to about 1.4 B. Rite Aid Current Liabilities is expected to significantly increase based on the last few years of reporting. The last year's Current Liabilities was at 2.77 Billion. The current year Tax Liabilities is expected to grow to about 73.7 M, whereas Liabilities Non Current is expected to decline to about 5.5 B.
The company has 7.12 B in debt with debt to equity (D/E) ratio of 740.8 . This implies that the company may be unable to create cash to meet all of its financial commitments. Rite Aid has Current Ratio of 1.5 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

CHAIRMAN Since

Douglas SandersSprouts Farmers Market
2015
Edward ShirleySysco
2020
Eric ShenVipshop Holdings Limited
2008
Brian CornellTarget
2014
Xiaobo HongVipshop Holdings Limited
2012
Jacquelyn WardSysco
2013
Robert McMasterSally Beauty Holdings
2016
Omar AsaliSpectrum Brands Holdings
2011
Ronald TysoeJ C Penney
2018
Thomas BeneSysco
2020
David MauraSpectrum Brands Holdings
2018
Gary WinterhalterSally Beauty Holdings
2014
Roxanne AustinTarget
2014
David CFASpectrum Brands Holdings
N/A
Thomas EngibousJ C Penney
N/A

Company Summary

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 29840 people.Rite Aid (RAD) is traded on BATS Exchange in USA and employs 29,840 people.

Rite Aid Leadership Team

Heyward Donigan, President, Chief Executive Officer, Director
Joseph Anderson, Independent Director
Elizabeth Burr, Independent Director
Douglas Donley, Chief Accounting Officer, Senior Vice President
Jim Peters, Chief Operating Officer
Michael Regan, Lead Independent Director
Arun Nayar, Independent Director
Brian Hoover, Chief Accounting Officer
David Jessick, Independent Director
Katherine Quinn, Independent Director
Myrtle Potter, Director
Bruce Bodaken, Independent Chairman of the Board
Kevin Lofton, Independent Director
Matt Schroeder, Group Vice President Strategy, Investor Relations and Treasurer
David Abelman, Executive Vice President - Marketing
Frank Savage, Independent Director
Kermit Crawford, President COO
Marcy Syms, Independent Director
James Comitale, Senior Vice President General Counsel, Secretary
Steve Rempel, Senior Vice President CIO
Justin Mennen, Senior Vice President, Chief Information Officer
Dedra Castle, Chief Human Resource Officer, Executive Vice President
Erik Keptner, Senior Vice President Chief Marketing Officer
Marc Strassler, Corporate Counsel
Kenneth Martindale, Pres and CEO of Rite Aid Stores
Derek Griffith, Executive Vice President - Store Operations
Enio Montini, Executive Vice President - Merchandising
Louis Miramontes, Independent Director
Darren Karst, CFO, Chief Admin. Officer and Sr. Executive VP
Jocelyn Konrad, Executive Vice President - Pharmacy and Retail Operations
Matthew Schroeder, Chief Financial Officer, Senior Vice President
Robert Knowling, Independent Director
Andre Persaud, Executive Vice President - Retail
Bryan Everett, Executive Vice President - Store Operations
Doug Donley, Chief Accounting Officer, Senior Vice President
John Standley, Chairman, CEO and Chairman of Executive Committee
James Peters, Chief Operating Officer

Stock Performance Indicators

Current Sentiment - RAD

Rite Aid Investor Sentiment

Predominant part of Macroaxis users are at this time bullish on Rite Aid. What is your perspective on investing in Rite Aid? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

NVDA   
Purchased over 40 shares of
few hours ago
Traded for 1.0
XOM   
Purchased over 200 shares of
few hours ago
Traded for 1.0
TLRY   
Purchased over 500 shares of
few hours ago
Traded for 1.0
UCO   
Purchased over 200 shares of
few hours ago
Traded for 1.0
CRON   
Purchased over 100 shares of
few hours ago
Traded for 1.0
Additionally, take a look at Your Equity Center. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page